cAMP-response element-binding protein mediates tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression in endothelial cells

Hypertension Research

Volumn 29, Issue 1, 2006, Pages 39-47

  Ono, Hiroki ^a   Ichiki, Toshihiro ^a   Ohtsubo, Hideki ^a   Fukuyama, Kae ^a   Imayama, Ikuyo ^a   Iino, Naoko ^a   Masuda, Satoko ^a   Hashiguchi, Yasuko ^a   Takeshita, Akira ^a   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Cytokine; Endothelial factors; Gene expression; Mitogen activated protein kinase; Signal transduction

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADENOVIRUS; ANGIOGENESIS; ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; DNA BINDING; DRUG TARGETING; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; HYPERTENSION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NORTHERN BLOTTING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VASCULAR ENDOTHELIUM;

ADENOVIRIDAE; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CATTLE; CELL NUCLEUS; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; GENETIC VECTORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33645237776     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.39     Document Type: Article

References (48)

1. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
2. Blann AD, Tse W, Maxwell SJ, Waite MA: Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 1994; 12: 925-928.
3. DeSouza CA, Dengel DR, Macko RF, Cox K, Seals DR: Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. Am J Hypertens 1997; 10: 1335-1341.
4. Parissis JT, Venetsanou KF, Mentzikof DG, et al: Plasma levels of soluble cellular adhesion molecules in patients with arterial hypertension. Correlations with plasma endothelin-1. Eur J Intern Med 2001; 12: 350-356.
5. Kohara K, Tabara Y, Yamamoto Y, Igase M, Nakura J, Miki T: Genotype-specific association between circulating soluble cellular adhesion molecules and carotid intimamedia thickness in community residents: J-SHIPP study. Shimanami Health Promoting Program. Hypertens Res 2002; 25: 31-39.
6. Iiyama K, Hajra L, Iiyama M, et al: Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999; 85: 199-207.
7. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA: The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 1995; 128: 1243-1253.
8. Pober JS, Cotran RS: The role of endothelial cells in inflammation. Transplantation 1990; 50: 537-544.
9. Krasinski K, Spyridopoulos I, Kearney M, Losordo DW: In vivo blockade of tumor necrosis factor-alpha accelerates functional endothelial recovery after balloon angioplasty. Circulation 2001; 104: 1754-1756.
10. Berk BC, Abe JI, Min W, Surapisitchat J, Yan C: Endothelial atheroprotective and anti-inflammatory mechanisms. Ann N Y Acad Sci 2001; 947: 93-111.
11. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC: Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 1992; 267: 16323-16329.
12. Shaywitz AJ, Greenberg ME: CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999; 68: 821-861.
13. Mayr B, Montminy M: Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001; 2: 599-609.
14. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 1991; 252: 1427-1430.
15. Xing J, Ginty DD, Greenberg ME: Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 1996; 273: 959-963.
16. Sugawara A, Takeuchi K, Uruno A, Kudo M, Sato K, Ito S: Effects of mitogen-activated protein kinase pathway and coactivator CREP-binding protein on peroxisome proliferator-activated receptor-γ-mediated transcription suppression of angiotensin II type 1 receptor gene. Hypertens Res 2003; 26: 623-628.
17. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb MJ: FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J 1996; 15: 4629-4642.
18. Du K, Montminy M: CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 1998; 273: 32377-32379.
19. Baud V, and Karin M: Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001; 11: 372-377.
20. Chen G, Goeddel DV: TNF-R1 signaling: a beautiful pathway. Science 2002; 296: 1634-1635.
21. Tokunou T, Ichiki T, Takeda K, et al: Thrombin induces interleukin-6 expression through the cAMP response element in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001; 21: 1759-1763.
22. Somers JP, DeLoia JA, Zeleznik AJ: Adenovirus-directed expression of a nonphosphorylatable mutant of CREB (cAMP response element-binding protein) adversely affects the survival, but not the differentiation, of rat granulosa cells. Mol Endocrinol 1999; 13: 1364-1372.
23. Funakoshi Y, Ichiki T, Ito K, Takeshita A: Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension 1999; 34: 118-125.
24. Frantz B, Klatt T, Pang M, et al: The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry 1998; 37: 13846-13853.
25. Ryder JW, Fahlman R, Wallberg-Henriksson H, Alessi DR, Krook A, Zierath JR: Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle. Involvement of the mitogen- and stress-activated protein kinase 1. J Biol Chem 2000; 275: 1457-1462.
26. Galan A, Garcia-Bermejo ML, Troyano A, et al: Stimulation of p38 mitogen-activated protein kinase is an early regulatory event for the cadmium-induced apoptosis in human promonocytic cells. J Biol Chem 2000; 275: 11418-11424.
27. Ahmad M, Theofanidis P, Medford RM: Role of activating protein-1 in the regulation of the vascular cell adhesion molecule-1 gene expression by tumor necrosis factor-alpha. J Biol Chem 1998; 273: 4616-4621.
28. Chinenov Y, Kerppola TK: Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001; 20: 2438-2452.
29. Stein B, Baldwin AS Jr, Ballard DW, Greene WC, Angel P, Herrlich P: Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 1993; 12: 3879-3891.
30. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995; 270: 16483-16486.
31. Ichiki T, Tokunou T, Fukuyama K, Iino N, Masuda S, Takeshita A: Cyclic AMP response element-binding protein mediates reactive oxygen species-induced c-fos expression. Hypertension 2003; 42: 177-183.
32. Funakoshi Y, Ichiki T, Takeda K, Tokunou T, Iino N, Takeshita A: Critical role of cAMP-response element-binding protein for angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 2002; 277: 18710-18717.
33. Ichijo H: From receptors to stress-activated MAP kinases. Oncogene 1999; 18: 6087-6093.
34. Kishore R, Luedemann C, Bord E, Goukassian D, Losordo DW: Tumor necrosis factor-mediated E2F1 suppression in endothelial cells: differential requirement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signal transduction pathways. Circ Res 2003; 93: 932-940.
35. Rousseau S, Houle F, Landry J, Huot J: p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 1997; 15: 2169-2177.
36. Matsumoto T, Turesson I, Book M, Gerwins P, Claesson-Welsh L: p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. J Cell Biol 2002; 156: 149-160.
37. Hale KK, Trollinger D, Rihanek M, Manthey CL: Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J Immunol 1999; 162: 4246-4252.
38. Lusis AJ: Atherosclerosis. Nature 2000; 407: 233-241.
39. Moore KL, Patel KD, Bruehl RE, et al: P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 1995; 128: 661-671.
40. Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, Wagner DD: The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 1998; 102: 145-152.
41. Gurtner GC, Davis V, Li H, McCoy MJ, Sharpe A, Cybulsky MI: Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev 1995; 9: 1-14.
42. Cybulsky MI, Iiyama K, Li H, et al: A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001; 107: 1255-1262.
43. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB: Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 2000; 20: 645-651.
44. Costanzo A, Moretti F, Burgio VL, et al: Endothelial activation by angiotensin II through NFkappaB and p38 pathways: involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J Cell Physiol 2003; 195: 402-410.
45. Yoshimoto T, Gochou N, Fukai N, Sugiyama T, Shichiri M, Hirata Y: Adrenomedullin inhibits angiotensin II-induced oxidative stress and gene expression in rat endothelial cells. Hypertens Res 2005; 28: 165-172.
46. Ju H, Behm DJ, Nerurkar S, et al: p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension. J Pharmacol Exp Ther 2003; 307: 932-938.
47. Xu Q, Liu Y, Gorospe M, Udelsman R, Holbrook J: Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest 1996; 97: 508-514.
48. Imai G, Satoh T, Kumai T, et al: Hypertension accelerates diabetic nephropathy in Wistar fatty rats, a model of type 2 diabetes mellitus, via mitogen-activated protein kinase cascades and transforming growth factor-beta1. Hypertens Res 2003; 26: 339-347.